Royalty Payment and Report. Beginning with the first sale of a Licensed Product, RIGEL shall make written reports (even if there are no sales in a particular quarter) and earned royalty payments to STANFORD within thirty (30) days after the end of each calendar quarter. This report shall be in the form of the report of Exhibit A and shall state the number, description, and aggregate Net Sales of Licensed Product(s) during such completed calendar quarter, and resulting calculation pursuant to Section 6.3 of earned royalty payments due STANFORD for such completed calendar quarter. Concurrent with the making of each such report, RIGEL shall include payment due STANFORD of earned royalties for the calendar quarter covered by such report.
Appears in 4 contracts
Samples: Collaboration Agreement (Rigel Pharmaceuticals Inc), Collaboration Agreement (Rigel Pharmaceuticals Inc), Collaboration Agreement (Rigel Pharmaceuticals Inc)
Royalty Payment and Report. Beginning with the first sale of a Licensed Product, RIGEL shall make written reports (even if there are no sales in a particular quartersales) and earned royalty payments to STANFORD within thirty (30) days after the end of each calendar quarter. This report shall be in the form of the report of Exhibit A B and shall state the number, description, and aggregate Net Sales of Licensed Product(s) during such completed calendar quarter, and resulting calculation pursuant to Section 6.3 Paragraph 6.4 of earned royalty payments payment due STANFORD for such completed calendar quarter. Concurrent with the making of each such report, RIGEL shall include payment due STANFORD of earned royalties for the calendar quarter covered by such report.
Appears in 4 contracts
Samples: Collaboration Agreement (Rigel Pharmaceuticals Inc), Collaboration Agreement (Rigel Pharmaceuticals Inc), Collaboration Agreement (Rigel Pharmaceuticals Inc)
Royalty Payment and Report. Beginning with the first sale of a Licensed Product, RIGEL shall make written reports (even if there are no sales in a particular quartersales) and earned royalty payments to STANFORD within thirty (30) days after the end of each calendar quarter. This report shall be in the form of the report of Exhibit A Appendix B and shall state the number, description, and aggregate Net Sales of Licensed Product(s) during such completed calendar quarter, and resulting calculation pursuant to Section 6.3 Paragraph 6.4 of earned royalty payments payment due STANFORD for such completed calendar quarter. Concurrent with the making of each such report, RIGEL shall include payment due STANFORD of earned royalties for the calendar quarter covered by such report.
Appears in 2 contracts
Samples: Collaboration Agreement (Rigel Pharmaceuticals Inc), Collaboration Agreement (Rigel Pharmaceuticals Inc)